[Aspects of new drug development].
Arai
Y
Y
Research and Development Dept. Ono Pharmaceutical Co., Ltd.
Urata
Y
Y
D002867:Chromones / Q000493:pharmacokinetics / Q000494:pharmacology / Q000627:therapeutic use; D002986:Clinical Trials as Topic; D015195:Drug Design; D006801:Humans; D007093:Imidazoles / Q000493:pharmacokinetics / Q000494:pharmacology / Q000627:therapeutic use; D020024:Leukotriene Antagonists; D011453:Prostaglandins / Q000493:pharmacokinetics / Q000627:therapeutic use; D013928:Thromboxane A2 / Q000031:analogs & derivatives / Q000037:antagonists & inhibitors* / Q000493:pharmacokinetics / Q000494:pharmacology / Q000627:therapeutic use; D013930:Thromboxane-A Synthase / Q000037:antagonists & inhibitors*
D002867:Chromones; D007093:Imidazoles; D020024:Leukotriene Antagonists; D011453:Prostaglandins; C029166:dazoxiben; D013928:Thromboxane A2; C049855:ONO 3708; D013930:Thromboxane-A Synthase; C047681:pranlukast